Creating a world-leading pipeline of precision gene medicines
Sutura is focussed on holistically addressing the genetic drivers that underpin debilitating and life-threatening conditions. Our most advanced programme will restore dystrophin protein expression within cardiac tissue of non-ambulant Duchenne Muscular Dystrophy (DMD) patients.
“We are a patient-orientated company that understands the complexity of those diseases that are most debilitating and life-threatening. We are striving to provide ‘all-stage’ disease modifying therapeutics to enhance the quality of life for humanity. Our precision gene medicine pipeline seeks to address these unmet clinical needs.”